Anesthesia can cause sustained hyperglycemia in C57/BL6J mice.

Area of Science:

• Neuroscience
• Pharmacology
• Animal Models

Background:

• Anesthesia is crucial for electroretinographic (ERG) studies in mice.
• Blood glucose (BG) levels can influence ERG amplitude.
• The impact of common anesthetics on BG in C57/BL6J mice is not fully understood.

Purpose of the Study:

• To evaluate the effects of four anesthetics (nembutal, pentothal, avertin, ketamine/xylazine) on blood glucose levels in C57/BL6J mice.
• To determine the duration of anesthetic-induced hyperglycemia.
• To provide guidance on anesthetic selection for ERG and metabolic research.

Main Methods:

• C57/BL6J mice were administered intraperitoneal injections of nembutal, pentothal, avertin, ketamine/xylazine, or saline.
• Blood glucose levels were measured from tail vein blood at baseline, 15 minutes, and 60 minutes post-injection.
• Statistical analysis was performed to compare BG changes between anesthetic groups and control.

Main Results:

• All tested anesthetics and saline transiently increased BG levels 15 minutes post-injection.
• Ketamine/xylazine and avertin induced significantly greater and more sustained BG elevations compared to nembutal, pentothal, and saline.
• Sixty minutes post-injection, BG levels remained elevated by 167% with ketamine/xylazine and 59% with avertin.

Conclusions:

• Ketamine/xylazine and avertin cause significant, prolonged hyperglycemia in mice, potentially affecting ERG recordings.
• Anesthetic choice is critical in studies where BG fluctuations could confound results, including diabetes and metabolism research.
• Caution is advised when using ketamine/xylazine or avertin in experiments sensitive to blood glucose levels.